陳萬青，1971年生，籍貫天津，中國醫學科學院腫瘤醫院研究員，博士生導師。1995年畢業于白求恩醫科大學臨床醫學系，2004年獲澳大利亞悉尼大學公共衛生學院國際公共衛生榮譽碩士學位，2014年獲悉尼大學Ph.D學位。1995年于中國醫學科學院腫瘤醫院放射治療科從事臨床工作5年，2005年回國后留任中國醫學科學院腫瘤醫院全國腫瘤防治研究辦公室副主任，2018年任癌癥早診早治辦公室主任，負責多項國家重大公共衛生項目。2016年晉升為研究員，2018年獲博士研究生導師資格。

研究方向為腫瘤流行病學，重點研究方向包括：我國常見癌癥篩查干預方案的流行病學和衛生經濟學評價研究，癌癥疾病負擔和經濟負擔研究。

爆草黑丝美女|韩国19禁无遮挡啪啪无码网站|91精品国产自产精品男人的天堂|sm鞭打高潮喷水抽搐调教玩弄|果冻在线|日本大尺度吃奶呻吟视频|久久久久黄片|北条麻妃av免费观看|中文字幕一区二区人妻|亚洲最大天堂无码精品区,日韩 欧美 国产精品,国产肉丝袜在线观看,最爽无遮挡行房视频,成人H视频在线观看,糖心vlog冉冉,蜜桃产品一二三产区

1. Li N#, Tan F#, Chen W#, Dai M#, Wang F, Shen S, Tang W, Li J, Yu Y, Cao W, Xu Y, Qin C, Zhao L, Zhu M, Guo L, Wu Z, Yang Z, Zheng Y, Chen H, Liu Y, Wei D, Dong D, Cao J, Zhang S, Yan S, Wang N, Du L, Shen H, Wu N, He J. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study. Lancet Respir Med. 2022, 10(4):378-91. (IF=102.642)

2. Xia R#, Li H#, Shi J#, Liu W, Cao M, Sun D, He S, Yu Y, Li N, Lei L, Zhuang G*, Chen W*. Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study. Gastrointest Endosc. 2022, 95(2):225-35.e20. (IF=10.396)

3. Li H#, Ding C#, Zeng H, Zheng R, Cao M, Ren J, Shi J, Sun D, He S, Yang Z, Yu Y, Zhang Z, Sun X, Guo G, Song G, Wei W, Chen W*, He J*. Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China. Cancer Commun (Lond). 2021, 41(8):715-725. (IF=10.392)

4. Chen W#*, Xia C#, Zheng R, Zhou M, Lin C, Zeng H, Zhang S, Wang L, Yang Z, Sun K, Li H, Brown MD, Islami F, Bray F, Jemal A, He J*. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. Lancet Glob Health. 2019, 7(2):e257-69. (IF=21.597, C100, ESI)

5. Zeng H#, Chen W*, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H, Wang N, Han R, Liu S, Li H, Mu H, He Y, Xu Y, Fu Z, Zhou Y, Jiang J, Yang Y, Chen J, Wei K, Fan D, Wang J, Fu F, Zhao D, Song G, Chen J, Jiang C, Zhou X, Gu X, Jin F, Li Q, Li Y, Wu T, Yan C, Dong J, Hua Z, Baade P, Bray F, Jemal A, Yu XQ, He J*. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018, 6(5):e555-67. (IF=15.873, C100, ESI, R)

6. Chen W#*, Zheng R, Zhang S, Zeng H, Xia C, Zuo T, Yang Z, Zou X, He J*. Cancer incidence and mortality in China, 2013. Cancer Let. 2017, 401:63-71. (IF=6.491, C100, ESI)

7. Islami F#*, Chen W*, Yu XQ, Lortet-Tieulent J, Zheng R, Flanders WD, Xia C, Thun MJ, Gapstur SM, Ezzati M, Jemal A. Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013. Ann Oncol. 2017, 28(10):2567-74. (IF=11.855, C100, ESI)

8. Chen W#*, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J*. Cancer statistics in China, 2015. CA Cancer J Clin. 2016, 66(2):115-32. (IF=187.04, C100, ESI)

9. Zhou M#, Wang H#, Zhu J#, Chen W#, Wang L, Liu S, Li Y, Wang L, Liu Y, Yin P, Liu J, Yu S, Tan F, Barber RM, Coates MM, Dicker D, Fraser M, González-Medina D, Hamavid H, Hao Y, Hu G, Jiang G, Kan H, Lopez AD, Phillips MR, She J, Vos T, Wan X, Xu G, Yan LL, Yu C, Zhao Y, Zheng Y, Zou X, Naghavi M, Wang Y*, Murray CJ*, Yang G*, Liang X*. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016, 387(10015):251-72. (IF= 47.831, C100, ESI)

10. Zeng H#, Zheng R#, Guo Y, Zhang S, Zou X, Wang N, Zhang L, Tang J, Chen J, Wei K, Huang S, Wang J, Yu L, Zhao D, Song G, Chen J, Shen Y, Yang X, Gu X, Jin F, Li Q, Li Y, Ge H, Zhu F, Dong J, Guo G, Wu M, Du L, Sun X, He Y, Coleman MP, Baade P, Chen W*, Yu XQ. Cancer survival in China, 2003-2005: a population-based study. Int J Cancer. 2015, 136(8):1921-30. (IF=6.513, C100, ESI)